TCIM
JNCE
TIAA CREF Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.11M | Buy |
178,427
+153,140
| +606% | +$949K | ﹤0.01% | 2274 |
|
|
2018
Q4 | $85K | Hold |
25,287
| – | – | ﹤0.01% | 2972 |
|
|
2018
Q3 | $164K | Sell |
25,287
-2,555
| -9% | -$16.6K | ﹤0.01% | 3015 |
|
|
2018
Q2 | $213K | Sell |
27,842
-916
| -3% | -$7.01K | ﹤0.01% | 3025 |
|
|
2018
Q1 | $643K | Hold |
28,758
| – | – | ﹤0.01% | 2640 |
|
|
2017
Q4 | $367K | Sell |
28,758
-13,434
| -32% | -$171K | ﹤0.01% | 2894 |
|
|
2017
Q3 | $657K | Sell |
42,192
-22,340
| -35% | -$348K | ﹤0.01% | 2711 |
|
|
2017
Q2 | $905K | Buy |
64,532
+54,119
| +520% | +$759K | ﹤0.01% | 2593 |
|
|
2017
Q1 | $229K | Buy |
+10,413
| New | +$229K | ﹤0.01% | 2969 |
|